Objective: Insulin stimulates glucose transport in skeletal muscle by GLUT4 translocation from intracellular compartments to sarcolemma and t-tubules. We studied in living animals the recruitment of GLUT4 vesicles in more detail than previously done and, for the first time, analyzed the steady-state recycling and subsequent re-internalization of GLUT4 on an insulin bolus.

Research Design And Methods: A confocal imaging technique was used in GLUT4-enhanced green fluorescent protein-transfected superficial muscle fibers in living mice.

Results: During the first 30 min of insulin stimulation, very few superficially or deeply located GLUT4 storage vesicles (>1 microm) moved in toto. Rather, big vesicles were stationary in their original position at sarcolemma or t-tubules and were locally depleted of GLUT4 by budding off of smaller vesicles. Photobleaching experiments revealed that during initial translocation and steady-state recycling, GLUT4 microvesicles (<1 microm) move from perinuclear GLUT4 depots out along the plasma membrane. Furthermore, after photobleaching of t-tubule areas, recovery of GLUT4 was slow or absent, indicating no recycling of GLUT4 from perinuclear or adjacent (1 microm) or more distant (20 microm) t-tubule areas. During waning of insulin effect, GLUT4 was re-internalized to basal stores with a delay in t-tubules compared with sarcolemma, probably reflecting delayed disappearance of insulin from t-tubules.

Conclusions: In skeletal muscle, insulin reversibly stimulates local depletion of GLUT4 storage vesicles at sarcolemma and t-tubules rather than inducing movement of intact storage vesicles. During steady-state stimulation, recycling of GLUT4-containing microvesicles over longer distances (10-20 microm) takes place between perinuclear depots and sarcolemma but not at t-tubules.

Download full-text PDF

Source
http://dx.doi.org/10.2337/db06-1578DOI Listing

Publication Analysis

Top Keywords

glut4 vesicles
8
vesicles stationary
8
insulin stimulation
8
skeletal muscle
8
glut4-enhanced green
8
green fluorescent
8
sarcolemma t-tubules
8
steady-state recycling
8
glut4
6
vesicles
5

Similar Publications

Dynamin-2 mutations linked to neonatal-onset centronuclear myopathy impair exocytosis and endocytosis in adrenal chromaffin cells.

J Neurochem

September 2024

Instituto de Fisiología, Biología Molecular y Neurociencias. CONICET. Departamento de Fisiología y Biología Molecular y Celular. Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires, Buenos Aires, Argentina.

Dynamins are large GTPases whose primary function is not only to catalyze membrane scission during endocytosis but also to modulate other cellular processes, such as actin polymerization and vesicle trafficking. Recently, we reported that centronuclear myopathy associated dynamin-2 mutations, p.A618T, and p.

View Article and Find Full Text PDF

Genetic deletion of zinc transporter ZnT induces progressive cognitive deficits in mice by impairing dendritic spine plasticity and glucose metabolism.

Front Mol Neurosci

May 2024

Department of Pharmacology, Center for Innovative Drug Research and Evaluation, Institute of Medical Science and Health, The Hebei Collaboration Innovation Center for Mechanism, Diagnosis and Treatment of Neurological and Psychiatric Disease, The Key Laboratory of Neural and Vascular Biology, Ministry of Education, Hebei Medical University, Shijiazhuang, Hebei, China.

Article Synopsis
  • Zinc transporter 3 (ZnT) is critical for regulating zinc levels in the brain, and its absence in mice leads to lower zinc levels and cognitive decline over time.
  • The study showed that ZnT knockout mice had increased dendritic complexity but a decrease in mature dendritic spine density, indicating potential issues with synaptic function.
  • Furthermore, ZnT deficiency was linked to reduced expression of key genes involved in insulin signaling, suggesting a connection between low zinc levels, impaired glucose metabolism, and cognitive impairment, which could inform new treatments for neurodegenerative diseases.
View Article and Find Full Text PDF
Article Synopsis
  • This study investigates how glucolipid metabolic disorders are linked to the use of the antipsychotic olanzapine, particularly focusing on the role of microRNAs in extracellular vesicles as potential biomarkers.
  • Researchers analyzed plasma EVs from patients undergoing olanzapine treatment and found that they can influence insulin sensitivity and metabolic health in experimental models.
  • The study identified significant differences in the miRNA profiles of patients based on their susceptibility to olanzapine-induced insulin resistance, highlighting miR-486-5p as a key player that could help improve insulin sensitivity when silenced.
View Article and Find Full Text PDF

Management of chronic obesity-associated metabolic disorders is a key challenge for biomedical researchers. During chronic obesity, visceral adipose tissue (VAT) undergoes substantial transformation characterized by a unique lipid-rich hypoxic AT microenvironment which plays a crucial role in VAT dysfunction, leading to insulin resistance (IR) and type 2 diabetes. Here, we demonstrate that obese AT microenvironment triggers the release of miR-210-3p microRNA-loaded extracellular vesicles from adipose tissue macrophages, which disseminate miR-210-3p to neighboring adipocytes, skeletal muscle cells, and hepatocytes through paracrine and endocrine actions, thereby influencing insulin sensitivity.

View Article and Find Full Text PDF

Background: Type 2 diabetes mellitus (T2DM), characterized by β-cell dysfunction and insulin resistance (IR), presents considerable treatment challenges. Apelin is an adipocyte-derived factor that shows promise in improving IR; however, it is limited by poor targeting and a short half-life. In the present study, engineered small extracellular vesicles (sEVs) derived from Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) loaded with apelin were used to address the limitations of the therapeutic application of apelin.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!